Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone furoate/vilanterol in persistent asthma
NCT01134042Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of vilanterol in asthma, sponsored by GSK. Started Jun 2010; status: completed.
02
Drugs
vilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01134042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01134042.